142 related articles for article (PubMed ID: 15850137)
1. Thymoquinone inhibits the activation of NF-kappaB in the brain and spinal cord of experimental autoimmune encephalomyelitis.
Mohamed A; Afridi DM; Garani O; Tucci M
Biomed Sci Instrum; 2005; 41():388-93. PubMed ID: 15850137
[TBL] [Abstract][Full Text] [Related]
2. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor.
Mohamed A; Shoker A; Bendjelloul F; Mare A; Alzrigh M; Benghuzzi H; Desin T
Biomed Sci Instrum; 2003; 39():440-5. PubMed ID: 12724933
[TBL] [Abstract][Full Text] [Related]
3. Piperlongumine attenuates experimental autoimmune encephalomyelitis through inhibition of NF-kappaB activity.
Gu SM; Yun J; Son DJ; Kim HY; Nam KT; Kim HD; Choi MG; Choi JS; Kim YM; Han SB; Hong JT
Free Radic Biol Med; 2017 Feb; 103():133-145. PubMed ID: 28011150
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the amelioration effects of two enzyme inducers on the inflammatory process of experimental allergic encephalitis (EAE) using immunohistochemical technique.
El-Gouhary I; Mohamed A; Suleiman S; Benghuzzi H
Biomed Sci Instrum; 2005; 41():376-81. PubMed ID: 15850135
[TBL] [Abstract][Full Text] [Related]
5. Rolipram impairs NF-kappaB activity and MMP-9 expression in experimental autoimmune encephalomyelitis.
Sánchez AJ; Puerta C; Ballester S; González P; Arriaga A; García-Merino A
J Neuroimmunol; 2005 Nov; 168(1-2):13-20. PubMed ID: 16182379
[TBL] [Abstract][Full Text] [Related]
6. Activation of nuclear factor-kB in the spinal cord of experimental allergic encephalomyelitis.
Pahan K; Schmid M
Neurosci Lett; 2000 Jun; 287(1):17-20. PubMed ID: 10841980
[TBL] [Abstract][Full Text] [Related]
7. Brain and spinal cord levels of histamine in Lewis rats with acute experimental autoimmune encephalomyelitis.
Orr EL; Stanley NC
J Neurochem; 1989 Jul; 53(1):111-8. PubMed ID: 2786054
[TBL] [Abstract][Full Text] [Related]
8. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
[TBL] [Abstract][Full Text] [Related]
9. Leuprolide Acetate Inhibits Spinal Cord Inflammatory Response in Experimental Autoimmune Encephalomyelitis by Suppressing NF-κB Activation.
Guzmán-Soto I; Salinas E; Quintanar JL
Neuroimmunomodulation; 2016; 23(1):33-40. PubMed ID: 26445405
[TBL] [Abstract][Full Text] [Related]
10. Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.
Yin L; Chen Y; Qu Z; Zhang L; Wang Q; Zhang Q; Li L
J Neuroimmunol; 2014 Sep; 274(1-2):28-37. PubMed ID: 25012120
[TBL] [Abstract][Full Text] [Related]
11. The use of digital technology to asses the severity of the Experimental Allergic Encephalomyelitis (EAE) spinal cord lesion.
Mohamed A; Tarhuni H; Dufan T; Benghuzzi H; Tucci M
Biomed Sci Instrum; 2004; 40():419-23. PubMed ID: 15133994
[TBL] [Abstract][Full Text] [Related]
12. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.
Sasaki M; Lankford KL; Brown RJ; Ruddle NH; Kocsis JD
Glia; 2010 Oct; 58(13):1523-31. PubMed ID: 20645414
[TBL] [Abstract][Full Text] [Related]
13. IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
Lee MJ; Bing SJ; Choi J; Jang M; Lee G; Lee H; Chang BS; Jee Y; Lee SJ; Cho IH
Mol Neurodegener; 2016 Jul; 11(1):54. PubMed ID: 27450563
[TBL] [Abstract][Full Text] [Related]
14. Antineuroinflammatory effect of NF-kappaB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis.
Dasgupta S; Jana M; Zhou Y; Fung YK; Ghosh S; Pahan K
J Immunol; 2004 Jul; 173(2):1344-54. PubMed ID: 15240729
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
Li XB; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
[TBL] [Abstract][Full Text] [Related]
16. Effects of Tripterygium glycoside treatment on experimental autoimmune encephalomyelitis.
Qiu J; You X; Wu G
Mol Med Rep; 2017 Dec; 16(6):8283-8288. PubMed ID: 28983582
[TBL] [Abstract][Full Text] [Related]
17. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
Panitch H; Ciccone C
Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
[TBL] [Abstract][Full Text] [Related]
18. Monoamines and related substances in brainstem and spinal cord of Lewis rats during the attack and recovery of experimental autoimmune encephalomyelitis.
Krenger W; Kabiersch A; Honegger CG
Brain Res; 1989 Jul; 491(2):374-8. PubMed ID: 2475212
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside spinal cord changes in chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rats.
Zaprianova E; Deleva D; Hauttecoeur B; Bakalska M; Filchev A
Neurochem Res; 1997 Feb; 22(2):175-9. PubMed ID: 9016843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
